Role listed
Molecular Diagnostics
AeroLeads people directory · profile
Thomas Ott Email & Phone Number
Director of Research and Development | IVD | Assay V&V
at
Molecular Diagnostics
2 work emails found
@quidel.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Director of Research and Development | IVD | Assay V&V
Location
San Diego, California, United States
Who is Thomas Ott? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Thomas Ott is listed as Director of Research and Development | IVD | Assay V&V at Molecular Diagnostics, based in San Diego, California, United States. AeroLeads shows a work email signal at quidel.com and a matched LinkedIn profile for Thomas Ott.
Thomas Ott previously worked as Director Of Research Development at Quidel and Associate Director, R&D at Quidel. Thomas Ott holds Doctor Of Philosophy (Ph.D.), Chemical Pathology Specializing In Molecular Biology from University Of Cape Town.
Company email context
Email format at Molecular Diagnostics
This section adds company-level context without repeating Thomas Ott's masked contact details.
{first}.{last}@quidel.com
89% confidence
AeroLeads found 2 current-domain work email signals for Thomas Ott. Compare company email patterns before reaching out.
Profile bio
About Thomas Ott
Ph.D. in Molecular Biology with over 15 years of industry experience, including a proven track record as an effective leader of diverse teams. Extensive expertise in advancing five PCR-based molecular in vitro diagnostic (IVD) platforms from early development through to global commercialization. Led product lines comprising more than 30 FDA-approved 510(k) test kits, generating over $700 million in revenue, including $120 million from non-COVID-19 products. Core Competencies:• Lead research teams from early discovery through verification studies, 510(k) submissions, and product launch.• Develop and implement actionable plans for efficient execution in fast-paced environments, with a strong ability to communicate complex concepts clearly.• Strong decision-maker skilled in analyzing and interpreting complex data to optimize and troubleshoot assay performance.• Develop strategies to identify and address critical assay and system parameters. • Direct cross-functional teams, collaborating with engineering, manufacturing, clinical, and quality assurance groups.• Proficient in managing product transfer from R&D to production, including process validation and documentation. • Expertise in developing, verifying, and validating assays, QC reagents, and workflows.• Experienced in instrument integration, from early prototypes to commercial platform launches.• Author documentation for internal and external reviews, including 510(k) submissions and CE marking.• Proven experience in managing multi-site operations and overseeing multiple shifts.• Oversee, mentor, and train scientists, junior staff, production, engineering, and QC personnel, fostering a collaborative team environment.• R&D software, database tools, and graphical user interface development.• Interface with upper management to communicate project status, issues and resource needs.• Design control, ISO 15189 and ISO13485
Listed skills include Assay Development, Biotechnology, Molecular Biology, In Vitro, and 16 others.
Current workplace
Thomas Ott's current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles
Thomas Ott work experience
A career timeline built from the work history available for this profile.
Director Of Research Development
CurrentLed the R&D team that developed the Savanna platform and Respiratory Virus Panel 4 (RVP4), the first Savanna product sold in Europe. Oversaw FDA submissions for RVP4+ emergency use and 510(k) applications, with 510(k) approval of the Savanna platform in December 2023. Key contributor to the development of lab software and database tools.
Mar 2022 - Present
Associate Director, R&D
Led the development of the Solana (real-time HDA assay) and early-stage Savanna (PCR-based, sample-to-result) platforms, managing process transfer to production and QC. Directed research teams in the creation of assay content, while overseeing hardware and software development. Led COVID-19 assay development for the Lyra and Lyra Direct platforms.
Sep 2015 - Mar 2022
Manager, Molecular R&D
Project lead for the development of Lyra Direct and two AmpliVue assays (Group B Streptococcus and Bordetella). The AmpliVue tests combine simple sample processing from Lyra Direct with isothermal helicase-dependent amplification (HDA) and a self-contained, disposable ELISA-based detection device. Both AmpliVue assays and multiple Lyra Direct products.
Feb 2013 - Sep 2015
Senior Scientist
Key contributor to the development of the first Lyra test kits for detecting Influenza A+B and C. difficile, including a novel, cost-effective sample preparation kit for the C. difficile Lyra Direct test. Both tests received CE marking and FDA approval. Led the development of five additional Lyra test kits, all achieving FDA approval and CE marking, with.
Apr 2010 - Feb 2013
Scientist
Led the development of a microfluidic PCR device with electric potential detection for Molecular Diagnostics at the Point of Care.
Feb 2009 - Apr 2010
Startup Contributor
Co-authored the first grant application for Crinetics Pharmaceuticals.
Sep 2008 - Feb 2009
Research Scientist
My work primarily focused on advancing early GPCR hits from HTS screens to drug candidates by developing assays in appropriate cell backgrounds to identify compounds suitable for animal testing and potential clinical development. This process involved cloning and mutating genes for expression in eukaryotic cell lines and harvesting tissues to characterize.
Jul 2004 - Aug 2008
Postdoctoral Scientist
Identified residues on CC chemokine receptor 7 and its agonists involved in high-affinity ligand binding and receptor activation. This required developing assay systems, including cAMP and various reporter assays. I optimized an electroporation protocol for large-scale transient transfections of mammalian cell lines to perform GTP-γS and radioligand.
Jul 2001 - Jul 2004
Postdoctoral Fellow
Hrsu Medical Research Council
Identified key ligand residues crucial for activity at the GnRH II receptor using radioligand binding, desensitization, and internalization assays. Investigated GnRH II receptor expression in various tissues through RNA protection assays, quantitative PCR, and Western blotting.Findings from these studies were reported in two publications:Millar R.P., Lowe.
Jun 2000 - May 2001
2 education records
Thomas Ott education
Doctor Of Philosophy (Ph.D.), Chemical Pathology Specializing In Molecular Biology
University Of Cape Town
Matrik And Abitur
Deutsche Höhere Privatschule Windhoek, Namibia
FAQ
Frequently asked questions about Thomas Ott
Quick answers generated from the profile data available on this page.
What company does Thomas Ott work for?
Thomas Ott works for Molecular Diagnostics.
What is Thomas Ott's role at Molecular Diagnostics?
Thomas Ott is listed as Director of Research and Development | IVD | Assay V&V at Molecular Diagnostics.
What is Thomas Ott's email address?
AeroLeads has found 2 work email signals at @quidel.com for Thomas Ott at Molecular Diagnostics.
Where is Thomas Ott based?
Thomas Ott is based in San Diego, California, United States while working with Molecular Diagnostics.
What companies has Thomas Ott worked for?
Thomas Ott has worked for Molecular Diagnostics, Quidel, Crinetics Pharmaceuticals, Acadia Pharmaceuticals, and Neurocrine Biosciences.
How can I contact Thomas Ott?
You can use AeroLeads to view verified contact signals for Thomas Ott at Molecular Diagnostics, including work email, phone, and LinkedIn data when available.
What schools did Thomas Ott attend?
Thomas Ott holds Doctor Of Philosophy (Ph.D.), Chemical Pathology Specializing In Molecular Biology from University Of Cape Town.
What skills is Thomas Ott known for?
Thomas Ott is listed with skills including Assay Development, Biotechnology, Molecular Biology, In Vitro, Drug Discovery, Cell Culture, Life Sciences, and Pcr.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial